Elesclomol restores mitochondrial function in genetic models of copper deficiency
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elesclomol restores mitochondrial function in genetic models of copper deficiency
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 115, Issue 32, Pages 8161-8166
Publisher
Proceedings of the National Academy of Sciences
Online
2018-07-24
DOI
10.1073/pnas.1806296115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The mitochondrion: a central architect of copper homeostasis
- (2017) Zakery N. Baker et al. Metallomics
- A phase I study of elesclomol sodium in patients with acute myeloid leukemia
- (2016) David Hedley et al. LEUKEMIA & LYMPHOMA
- Cooperation between COA6 and SCO2 in COX2 Maturation during Cytochrome c Oxidase Assembly Links Two Mitochondrial Cardiomyopathies
- (2015) David Pacheu-Grau et al. Cell Metabolism
- Pharmacological activity of metal binding agents that alter copper bioavailability
- (2015) Marian E. Helsel et al. DALTON TRANSACTIONS
- Mitochondrial disease genesCOA6,COX6BandSCO2have overlapping roles in COX2 biogenesis
- (2015) Alok Ghosh et al. HUMAN MOLECULAR GENETICS
- COA6 is a mitochondrial complex IV assembly factor critical for biogenesis of mtDNA-encoded COX2
- (2015) David A. Stroud et al. HUMAN MOLECULAR GENETICS
- Redox-regulated dynamic interplay between Cox19 and the copper-binding protein Cox11 in the intermembrane space of mitochondria facilitates biogenesis of cytochrome c oxidase
- (2015) Manuela Bode et al. MOLECULAR BIOLOGY OF THE CELL
- Mutations causing mitochondrial disease: What is new and what challenges remain?
- (2015) R. N. Lightowlers et al. SCIENCE
- Copper supplementation restores cytochrome c oxidase assembly defect in a mitochondrial disease model of COA6 deficiency
- (2014) A. Ghosh et al. HUMAN MOLECULAR GENETICS
- Mutations inCOA6cause CytochromecOxidase Deficiency and Neonatal Hypertrophic Cardiomyopathy
- (2014) Fabian Baertling et al. HUMAN MUTATION
- Oral Treatment with CuII(atsm) Increases Mutant SOD1 In Vivo but Protects Motor Neurons and Improves the Phenotype of a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
- (2014) B. R. Roberts et al. JOURNAL OF NEUROSCIENCE
- Copper Import into the Mitochondrial Matrix in Saccharomyces cerevisiae Is Mediated by Pic2, a Mitochondrial Carrier Family Protein
- (2013) Katherine E. Vest et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma
- (2013) Steven J. O'Day et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II), Ni(II) and Pt(II)
- (2013) Arun A. Yadav et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells
- (2012) Masazumi Nagai et al. FREE RADICAL BIOLOGY AND MEDICINE
- Effect of copper and disulfiram combination therapy on the macular mouse, a model of Menkes disease
- (2012) Wattanaporn Bhadhprasit et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search